CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study) The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction Intravascular ultrasound guidance of percutaneous coronary intervention in ostial chronic total occlusions: a description of the technique and procedural results A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement Current clinical applications of coronary optical coherence tomography

Original ResearchVolume 73, Issue 18, 14 May 2019, Pages 2267-2282

JOURNAL:J Am Coll Cardiol. Article Link

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure

CK Nagaraju, EL Robinson, KR Sipido et al. Keywords: contractile function extracellular matrix fibroblasts inflammation

FULL TEXT PDF